January 30, 2025

Supine Hypertension: A Missed Opportunity in CVD Prevention?

Study finds supine hypertension independently increases cardiovascular disease risk.

Conexiant

January 30, 2025

GFAP Blood Test May Expedite Stroke Diagnosis

Novel blood biomarker GFAP shows 90-95% accuracy in differentiating hemorrhagic from ischemic strokes pre-hospitalization.

Conexiant

January 29, 2025

Autism Risk Differs Across Antiseizure Meds

Prenatal exposure to valproate increases autism risk, while topiramate and lamotrigine show no significant link, study finds.

Conexiant

January 29, 2025

ACEP: HBO₂ Maintains Level C in CO Poisoning

New review finds modest benefits, but barriers to implementation remain

Conexiant

January 29, 2025

Cholesterol Variability Linked to Dementia Risk

Study of 9846 older adults shows higher total cholesterol and LDL-c variability associated with increased dementia risk and accelerated cognitive decline over a 5.8-year follow-up, independent of mean lipid levels.

Conexiant

January 28, 2025

Heavy Cannabis Use Linked to Altered Memory Processing

New research examining 1003 young adults shows persistent reductions in working memory-related brain activation among heavy cannabis users, independent of recent use or substance dependence diagnosis.

Conexiant

January 28, 2025

Trial Data Behind FDA Psychiatric Approvals

Key trial data and insights behind US Food and Drug Administration approvals of novel psychiatric drugs are shown, highlighting methods, demographics, and pivotal outcomes.

Conexiant

January 27, 2025

Autism Risk Differs Across Antiseizure Meds

Prenatal exposure to valproate increases autism risk, while topiramate and lamotrigine show no significant link, study finds.

Conexiant

January 27, 2025

FDA Approves New Leqembi Dosing Regimen

Leqembi gains FDA approval for updated intravenous dosing schedule for early Alzheimer’s disease.

Conexiant